Gene Editing in Human Lymphoid Cells: Role for Donor DNA, Type of Genomic Nuclease and Cell Selection Method

Viruses
Anastasia ZotovaDmitriy Mazurov

Abstract

Programmable endonucleases introduce DNA breaks at specific sites, which are repaired by non-homologous end joining (NHEJ) or homology recombination (HDR). Genome editing in human lymphoid cells is challenging as these difficult-to-transfect cells may also inefficiently repair DNA by HDR. Here, we estimated efficiencies and dynamics of knockout (KO) and knockin (KI) generation in human T and B cell lines depending on repair template, target loci and types of genomic endonucleases. Using zinc finger nuclease (ZFN), we have engineered Jurkat and CEM cells with the 8.2 kb human immunodeficiency virus type 1 (HIV-1) ∆Env genome integrated at the adeno-associated virus integration site 1 (AAVS1) locus that stably produce virus particles and mediate infection upon transfection with helper vectors. Knockouts generated by ZFN or clustered regularly interspaced short palindromic repeats (CRISPR/Cas9) double nicking techniques were comparably efficient in lymphoid cells. However, unlike polyclonal sorted cells, gene-edited cells selected by cloning exerted tremendous deviations in functionality as estimated by replication of HIV-1 and human T cell leukemia virus type 1 (HTLV-1) in these cells. Notably, the recently reported high-fidelity...Continue Reading

References

Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y G KimS Chandrasegaran
Jul 3, 2007·Nature Biotechnology·Jeffrey C MillerEdward J Rebar
Jul 28, 2010·Genetics·Michelle ChristianDaniel F Voytas
Dec 24, 2010·Nature Biotechnology·Jeffrey C MillerEdward J Rebar
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Mar 7, 2014·The New England Journal of Medicine·Pablo TebasCarl H June
Jun 14, 2014·Proceedings of the National Academy of Sciences of the United States of America·Lin YeYuet Wai Kan
Dec 3, 2015·Science·Ian M SlaymakerFeng Zhang
May 6, 2016·Annual Review of Biochemistry·Haifeng WangLei S Qi
Oct 18, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Bingjie ShiLinqi Zhang
Jan 27, 2017·Science Translational Medicine·Waseem QasimPaul Veys
Sep 21, 2017·Nature·Janice S ChenJennifer A Doudna

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
gene knockout
fluorescence-activated cell sorting
PCR
PMA
ELISA
FACS
Flow Cytometry
transgenic
transfection

Software Mentioned

HypaCas9
CytExpert
FlowJo

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.